Drugmaker Johnson & Johnson says it will be able to provide 20 million U.S. doses of its single-shot COVID-19 vaccine by the end of March, assuming it gets the greenlight from federal regulators.
J&J disclosed the figure ahead of a Congressional hearing on Tuesday looking at the country's vaccine supply. White House officials cautioned last week that initial supplies of J&J's vaccine would be limited.
COVID-19 vaccine could cause mammogram result confusion, doctors say
The company reiterated that it will have capacity to provide 100 million vaccine doses to the U.S. by the end of June. That supply will help government officials reach the goal of having enough injections to vaccinate most adult Americans later this year. On a global scale, the company aims to produce 1 billion doses this year.
You received a second dose of the COVID-19 vaccine. Now what?
U.S. health regulators are still reviewing the safety and effectiveness of the shot and a decision to allow its emergency use is expected later this week. J&J's vaccine would be the first in the U.S. that requires only a single shot.
Pfizer and Moderna vaccines require two doses spaced weeks apart. Executives from both companies and two other vaccine makers will also testify at Tuesday's hearing.
How do we know the COVID-19 vaccines are safe?
On Tuesday, Dr. Anthony Fauci was asked about distribution of the J&J vaccine once it's approved.
"What we're seeing is that, instead of being front loaded with the number of doses that are coming out, it very likely will be back loaded," he said. "And by that I mean we are now -- they're in full consideration with the FDA for an emergency use authorization, I don't want to get ahead of the FDA, but if, in fact, that that is given to them, they're not going to have a lot of doses on the first day. It will likely be relatively few, which will then scale up a lot more. And it's just matter of what happened with their production capability and how they are now going to be revving up. Then soon after that they're going to have a lot of doses. But it's not going to be front loaded."
Johnson & Johnson says it will be able to provide 20 million COVID-19 vaccine doses by end of March
More TOP STORIES News